Anzeige
Mehr »
Montag, 07.07.2025 - Börsentäglich über 12.000 News
Surfen Sie die heißeste Edelmetall-Welle des Jahrzehnts! Dieses TOP-Unternehmen zündet nächste Wachstumsstufe!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
23 Leser
Artikel bewerten:
(0)

$56.6 million valuation for WebDoctor as VentureWave Capital invests $3.54 million

DUBLIN, Ireland, Sept. 15, 2021 /PRNewswire/ -- WebDoctor, the Irish health technology platform, has received a $3.54 million investment from VentureWave Capital, the venture private equity investor that focuses on entrepreneurial companies with high impact potential. The investment gives a valuation of $56.6 million to the business and will be used to accelerate WebDoctor's international growth and expansion and the scaling of the sales, marketing, product and technology teams.

Alan Foy (left), Chairman and Managing Partner, VentureWave Capital and David Crimmins, CEO, WebDoctor.

WebDoctor is a leading health technology business and telehealth platform which enables engagement and collaboration between healthcare practitioners and their patients. Since its establishment in 2013, the company has processed over three million bookings to GP's, pharmacies and other health-related clinics and has registered almost ten per cent of the Irish population as patients on its platform. In response to Covid-19, the year on year increase in GP appointments has risen from 68,000 in 2020 to 125,000 in the current year.

WebDoctor was originally founded when brothers Oisin and Howard Kim and co-founder Martin Commins helped a family friend, Dr Sylvester Mooney, transform his medical clinic's business. Today WebDoctor enables doctors to conduct their day-to-day operations virtually and to automate their booking and payment processes; and patients can attend virtual consultations at a lower cost than in-person appointments.

The demand for telehealth during Covid has skyrocketed with WebDoctor itself experiencing a 75% increase in revenue from 2019 to 2020. VentureWave Capital's team will work alongside WebDoctor executives, including newly appointed CEO David Crimmins, to drive the company's post-pandemic growth and its expansion into new markets. CEO David Crimmins, formerly of ResMed, the global leader in connected medical devices, has previously launched and marketed products internationally, with P&L responsibility for multimillion euro budgets. VentureWave Capital Chairman and Managing Partner, Alan Foy, will join WebDoctor's board of directors.

WebDoctor is consistent with the objectives of VentureWave Capital to deliver social outcomes in its investment mandate. These include reduced cost and easier accessibility for patients, support for healthcare professionals seeking flexible work arrangements and reduced carbon emissions through fewer journeys to and energy costs at GPs' clinics.

Alan Foy, Chairman and Managing Partner VentureWave Capital, said: "We are excited to invest in WebDoctor - a successful, scaling Irish health technology business with a really strong team of promoters and entrepreneurs. WebDoctor is a great example of an Irish company with an excellent market opportunity, proven team and exemplary technology / product platform. We look forward to supporting the team in their future scaling. We are confident the team will drive new opportunities to make an impact on the next phase of their successful journey".

Kieran McLoughlin, VentureWave Capital Managing Partner said: "Our Global and Irish investors are committed to backing great companies that generate both financial and social returns. Together with David and the WebDoctor team, we have set significant Impact goals for the next 10 years including serving 15 million patients and supporting 500 healthcare professionals seeking flexible work. WebDoctor's business is aligned with our fundamental objective of generating profit with a purpose."

David Crimmins, CEO, WebDoctor stated: "VentureWave Capital's investment comes at a pivotal time for WebDoctor, enabling us to meet the exponential growth of the telehealth market and operate on an international scale. This is an exciting time for the company as we look to build upon our success working with partners in Ireland, the UK, Germany, Australia by driving the business internationally."

Noel McSweeney, Chairman, WebDoctor said: "Against the backdrop of Covid-19 the team has been working on the strategic development of the business and the investment by VentureWave Capital is a clear recognition of our potential as we look towards a positive future."

Photo - https://mma.prnewswire.com/media/1626097/1093576_image.jpg

© 2021 PR Newswire
Die USA haben fertig! 5 Aktien für den China-Boom
Die Finanzwelt ist im Umbruch! Nach Jahren der Dominanz erschüttert Donald Trumps erratische Wirtschaftspolitik das Fundament des amerikanischen Kapitalismus. Handelskriege, Rekordzölle und politische Isolation haben eine Kapitalflucht historischen Ausmaßes ausgelöst.

Milliarden strömen aus den USA – und suchen neue, lukrative Ziele. Und genau hier kommt China ins Spiel. Trotz aller Spannungen wächst die chinesische Wirtschaft dynamisch weiter, Innovation und Digitalisierung treiben die Märkte an.

Im kostenlosen Spezialreport stellen wir Ihnen 5 Aktien aus China vor, die vom US-Niedergang profitieren und das Potenzial haben, den Markt regelrecht zu überflügeln. Wer jetzt klug investiert, sichert sich den Zugang zu den neuen Wachstums-Champions von morgen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche 5 Aktien die Konkurrenz aus den USA outperformen dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.